Cargando…

The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research

Spondylarthritis (SpA) is an umbrella term that encompasses a wide range of rheumatological disorders. Several studies demonstrated that SpA is associated with increased healthcare resource utilization (HCRU) and a lower health-related quality of life (HRQoL). This review aimed to summarize the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Rayes, Hanan, Salah, Hany, Hamad, Tharwat, Soliman, Mohab, Bedaiwi, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497044/
https://www.ncbi.nlm.nih.gov/pubmed/37705696
http://dx.doi.org/10.2147/OARRR.S414530
_version_ 1785105223169081344
author Al Rayes, Hanan
Salah, Hany
Hamad, Tharwat
Soliman, Mohab
Bedaiwi, Mohamed
author_facet Al Rayes, Hanan
Salah, Hany
Hamad, Tharwat
Soliman, Mohab
Bedaiwi, Mohamed
author_sort Al Rayes, Hanan
collection PubMed
description Spondylarthritis (SpA) is an umbrella term that encompasses a wide range of rheumatological disorders. Several studies demonstrated that SpA is associated with increased healthcare resource utilization (HCRU) and a lower health-related quality of life (HRQoL). This review aimed to summarize the current literature regarding the multidimensional impact of SpA on HRQoL and HCRU in Saudi Arabia and explore the correlation of the extent of severity of SpA with HRQoL and HCRU. Although the prevalence of SpA varies across different populations and is correlated with HLA-B27 prevalence, the magnitude of SpA in the Saudi population has not been extensively evaluated. Few studies have investigated the impact of SpA on HRQoL and HCRU in Saudi Arabia and the Middle East. There is a need to study the cost-effectiveness of various SpA treatment strategies, including biologic disease-modifying anti-rheumatic drugs (bDMARDs), to prioritize healthcare spending in the Saudi healthcare system. Data on SpA in Saudi Arabia and the Middle East region are mainly based on expert views, with few population-based studies compared to other regions. Therefore, there is an imperative need to develop high-quality, national-level epidemiological studies that assess the following: (1) more accurate estimates of the current prevalence of SpA in Saudi Arabia, including the prevalence of axial SpA and psoriatic arthritis; (2) the phenotypes/clinical characteristics of SpA, including disease severity and extra-articular involvement; (3) the impact of SpA on the HRQoL of the patients and the factors that can predict the extent of impaired HRQoL in such population, which can represent the first step in developing psychological interventions that should be personalized to this patient population; (4) the impact of implementing formal assessment of disease activity on the management of the patients and, subsequently, their HRQoL; and (5) the HCRU and costs for patients with SpA, and how treatment patterns can affect this cost.
format Online
Article
Text
id pubmed-10497044
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104970442023-09-13 The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research Al Rayes, Hanan Salah, Hany Hamad, Tharwat Soliman, Mohab Bedaiwi, Mohamed Open Access Rheumatol Review Spondylarthritis (SpA) is an umbrella term that encompasses a wide range of rheumatological disorders. Several studies demonstrated that SpA is associated with increased healthcare resource utilization (HCRU) and a lower health-related quality of life (HRQoL). This review aimed to summarize the current literature regarding the multidimensional impact of SpA on HRQoL and HCRU in Saudi Arabia and explore the correlation of the extent of severity of SpA with HRQoL and HCRU. Although the prevalence of SpA varies across different populations and is correlated with HLA-B27 prevalence, the magnitude of SpA in the Saudi population has not been extensively evaluated. Few studies have investigated the impact of SpA on HRQoL and HCRU in Saudi Arabia and the Middle East. There is a need to study the cost-effectiveness of various SpA treatment strategies, including biologic disease-modifying anti-rheumatic drugs (bDMARDs), to prioritize healthcare spending in the Saudi healthcare system. Data on SpA in Saudi Arabia and the Middle East region are mainly based on expert views, with few population-based studies compared to other regions. Therefore, there is an imperative need to develop high-quality, national-level epidemiological studies that assess the following: (1) more accurate estimates of the current prevalence of SpA in Saudi Arabia, including the prevalence of axial SpA and psoriatic arthritis; (2) the phenotypes/clinical characteristics of SpA, including disease severity and extra-articular involvement; (3) the impact of SpA on the HRQoL of the patients and the factors that can predict the extent of impaired HRQoL in such population, which can represent the first step in developing psychological interventions that should be personalized to this patient population; (4) the impact of implementing formal assessment of disease activity on the management of the patients and, subsequently, their HRQoL; and (5) the HCRU and costs for patients with SpA, and how treatment patterns can affect this cost. Dove 2023-09-08 /pmc/articles/PMC10497044/ /pubmed/37705696 http://dx.doi.org/10.2147/OARRR.S414530 Text en © 2023 Al Rayes et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Al Rayes, Hanan
Salah, Hany
Hamad, Tharwat
Soliman, Mohab
Bedaiwi, Mohamed
The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research
title The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research
title_full The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research
title_fullStr The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research
title_full_unstemmed The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research
title_short The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research
title_sort impact of spondyloarthritis on health-related quality of life and healthcare resource utilization in saudi arabia: a narrative review and directions for future research
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497044/
https://www.ncbi.nlm.nih.gov/pubmed/37705696
http://dx.doi.org/10.2147/OARRR.S414530
work_keys_str_mv AT alrayeshanan theimpactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT salahhany theimpactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT hamadtharwat theimpactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT solimanmohab theimpactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT bedaiwimohamed theimpactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT alrayeshanan impactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT salahhany impactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT hamadtharwat impactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT solimanmohab impactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch
AT bedaiwimohamed impactofspondyloarthritisonhealthrelatedqualityoflifeandhealthcareresourceutilizationinsaudiarabiaanarrativereviewanddirectionsforfutureresearch